What changed
$APD — Produces industrial gases for manufacturing and healthcare.
🎯 Q1 FY26 | Rev $3B | EPS $3.20 vs $3.06 🟢 | Margin 23.7%
💡 Consensus expects FY2026 EPS of ~$13.21, implying modest growth from the $12.80 trailing run-rate. The market is undervaluing the structural improvement in operating margins (23.7% vs. negative prior year) and the potential for helium supply chain disruptions to boost pricing power.
🏢 Business Quality: 8/10 | Valuation: fair
📉 Reward/Risk: Upside 12% to $313 (23x FY2026 EPS of $13.60) vs downside 8% to $257 (20x $12.85). Ratio ~1.5:1.
🔮 Catalyst: Next earnings (early Aug 2026): Q3 FY2026 report. Watch for EPS > $3.53 (consensus) and raised FY guidance. Failure signal: EPS misses or guidance cut.
💰 Entry: Current price $279.63 is attractive within a $270-$285 range. Ideal entry below $275.
Also in play: $SWKS $QRVO $MTSI $DIOD $TXN $TSM